Literature DB >> 23595630

Radiologic and clinical predictors of malignancy in the follicular lesion of undetermined significance of the thyroid.

Ryan Carr1, Berrin Ustun, David Chhieng, Kevin Schofield, Constantine Theoharis, Lynwood Hammers, Adebowale J Adeniran.   

Abstract

Various ultrasonographic characteristics of thyroid nodules have been associated with a higher likelihood of malignancy, and certain clinical features may also increase the likelihood of malignancy in patients. This study is designed to determine the ultrasonographic and clinical predictors of malignancy in the atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS) category. A search through the cytology files at our institution was made for cases with diagnosis of AUS/FLUS. The clinical and radiologic findings were correlated with the final surgical pathology diagnosis. A total of 140 cases of AUS/FLUS with corresponding surgical intervention were identified (112 females and 28 males). There was a 79 % malignancy rate in nodules with irregular contours, compared to 51 % in nodules with regular outlines. Nodules demonstrating calcifications showed a 57 % malignancy rate, compared to 50 % in nodules without calcifications. Sixty-one percent of cases with an ultrasonographic diagnosis of indeterminate to suspicious were malignant following surgical resection. The rates of malignancy in patients with radiation exposure, symptomatic nodules, and positive family history of thyroid cancer were 22, 59, and 33 %, respectively. BRAF mutation was demonstrated in 57 % of malignant cases and in none of benign cases. No single clinical or ultrasonographic feature or combination of features is adequately sensitive or specific to identify all malignant nodules. However, a combination of solid nodules, nodules with irregular contours, symptomatic nodules, and positive BRAF mutation has high predictive value for malignancy in patients with a cytologic diagnosis of AUS/FLUS.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23595630     DOI: 10.1007/s12022-013-9240-4

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  33 in total

1.  Thyroid fine-needle aspiration with atypia of undetermined significance: a necessary or optional category?

Authors:  Yan Shi; Xin Ding; Melissa Klein; Chiara Sugrue; Sandra Matano; Morris Edelman; Patricia Wasserman
Journal:  Cancer       Date:  2009-10-25       Impact factor: 6.860

2.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Authors:  David S Cooper; Gerard M Doherty; Bryan R Haugen; Bryan R Hauger; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Furio Pacini; Martin Schlumberger; Steven I Sherman; David L Steward; R Michael Tuttle
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

3.  The Bethesda System for Reporting Thyroid Cytopathology.

Authors:  Edmund S Cibas; Syed Z Ali
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

4.  The Bethesda thyroid fine-needle aspiration classification system: year 1 at an academic institution.

Authors:  Constantine G A Theoharis; Kevin M Schofield; Lynwood Hammers; Robert Udelsman; David C Chhieng
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

5.  Fine needle aspiration cytology of the thyroid, 1980 to 1986.

Authors:  J R Goellner; H Gharib; C S Grant; D A Johnson
Journal:  Acta Cytol       Date:  1987 Sep-Oct       Impact factor: 2.319

Review 6.  Fine-needle aspiration biopsy of thyroid nodules: advantages, limitations, and effect.

Authors:  H Gharib
Journal:  Mayo Clin Proc       Date:  1994-01       Impact factor: 7.616

7.  Immunohistochemical markers in diagnosis of papillary thyroid carcinoma: Utility of HBME1 combined with CK19 immunostaining.

Authors:  Michel R Nasr; Sanjay Mukhopadhyay; Shengle Zhang; Anna-Luise A Katzenstein
Journal:  Mod Pathol       Date:  2006-09-22       Impact factor: 7.842

8.  Thyroid follicular lesion of undetermined significance: Evaluation of the risk of malignancy using the two-tier sub-classification.

Authors:  Matthew J Horne; David C Chhieng; Constantine Theoharis; Kevin Schofield; Diane Kowalski; Manju L Prasad; Lynwood Hammers; Robert Udelsman; Adebowale J Adeniran
Journal:  Diagn Cytopathol       Date:  2011-08-26       Impact factor: 1.582

9.  Effect of the Bethesda system for reporting thyroid cytopathology on thyroidectomy rates and malignancy risk in cytologically indeterminate lesions.

Authors:  Jennifer L Rabaglia; Wareef Kabbani; Lucy Wallace; Shelby Holt; Lori Watumull; Jeffrey Pruitt; William H Snyder; Fiemu E Nwariaku
Journal:  Surgery       Date:  2010-12       Impact factor: 3.982

10.  The National Cancer Institute Thyroid fine needle aspiration state of the science conference: a summation.

Authors:  Zubair W Baloch; Edmund S Cibas; Douglas P Clark; Lester J Layfield; Britt-Marie Ljung; Martha Bishop Pitman; Andrea Abati
Journal:  Cytojournal       Date:  2008-04-07       Impact factor: 2.091

View more
  8 in total

1.  Surgical treatment of thyroid follicular neoplasms: results of a retrospective analysis of a large clinical series.

Authors:  Giovanni Conzo; Nicola Avenia; Gian Luca Ansaldo; Piergiorgio Calò; Maurizio De Palma; Chiara Dobrinja; Giovanni Docimo; Claudio Gambardella; Marica Grasso; Celestino Pio Lombardi; Maria Rosa Pelizzo; Angela Pezzolla; Luciano Pezzullo; Micaela Piccoli; Lodovico Rosato; Giuseppe Siciliano; Stefano Spiezia; Ernesto Tartaglia; Francesco Tartaglia; Mario Testini; Giancarlo Troncone; Giuseppe Signoriello
Journal:  Endocrine       Date:  2016-04-13       Impact factor: 3.633

2.  Strategy to reduce unnecessary surgeries in thyroid nodules with cytology of Bethesda category III (AUS/FLUS): a retrospective analysis of 667 patients diagnosed by surgery.

Authors:  Yong Joon Suh; Yeon Ju Choi
Journal:  Endocrine       Date:  2020-04-15       Impact factor: 3.633

3.  Malignancy is associated with microcalcification and higher AP/T ratio in ultrasonography, but not with Hashimoto's thyroiditis in histopathology in patients with thyroid nodules evaluated as Bethesda Category III (AUS/FLUS) in cytology.

Authors:  Oya Topaloglu; Husniye Baser; Fatma Neslihan Cuhaci; Nuran Sungu; Abdussamed Yalcin; Reyhan Ersoy; Bekir Cakir
Journal:  Endocrine       Date:  2016-05-12       Impact factor: 3.633

Review 4.  Pitfalls in Thyroid Cytopathology.

Authors:  Esther Diana Rossi; Adebowale J Adeniran; William C Faquin
Journal:  Surg Pathol Clin       Date:  2019-12

5.  Repeat Diagnoses of Bethesda Category III Thyroid Nodules: What To Do Next?

Authors:  Mi Ri Yoo; Hye Mi Gweon; Ah Young Park; Kyung Eun Cho; Jeong-Ah Kim; Ji Hyun Youk; Eun Ju Son
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

Review 6.  Ultrasound is helpful to differentiate Bethesda class III thyroid nodules: A PRISMA-compliant systematic review and meta-analysis.

Authors:  Lu-Ying Gao; Ying Wang; Yu-Xin Jiang; Xiao Yang; Ru-Yu Liu; Xue-Hua Xi; Shen-Ling Zhu; Rui-Na Zhao; Xing-Jian Lai; Xiao-Yan Zhang; Bo Zhang
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

7.  Ultrasound characteristics of thyroid nodules facilitate interpretation of the malignant risk of Bethesda system III/IV thyroid nodules and inform therapeutic schedule.

Authors:  Fu Li; Denghua Pan; Yuquan Wu; Jinbo Peng; Qing Li; Xiaolong Gui; Wei Ma; Hong Yang; Yun He; Junqiang Chen
Journal:  Diagn Cytopathol       Date:  2019-06-18       Impact factor: 1.582

8.  Diagnosis of atypia/follicular lesion of undetermined significance: An institutional experience.

Authors:  Lawrence Q Wong; Virginia A LiVolsi; Zubair W Baloch
Journal:  Cytojournal       Date:  2014-08-28       Impact factor: 2.091

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.